nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—Splenomegaly—Varenicline—nicotine dependence	0.0421	0.0601	CcSEcCtD
Lamivudine—PCYT1A—cardiovascular system—nicotine dependence	0.0355	0.118	CbGeAlD
Lamivudine—Hoarseness—Varenicline—nicotine dependence	0.0266	0.0379	CcSEcCtD
Lamivudine—PCYT2—brain—nicotine dependence	0.0256	0.0854	CbGeAlD
Lamivudine—NME1—cardiovascular system—nicotine dependence	0.0237	0.0792	CbGeAlD
Lamivudine—CMPK1—cardiovascular system—nicotine dependence	0.0229	0.0764	CbGeAlD
Lamivudine—Suicide—Varenicline—nicotine dependence	0.0225	0.0322	CcSEcCtD
Lamivudine—NME2—cardiovascular system—nicotine dependence	0.0223	0.0746	CbGeAlD
Lamivudine—PGK1—brain—nicotine dependence	0.022	0.0734	CbGeAlD
Lamivudine—Suicide attempt—Varenicline—nicotine dependence	0.0206	0.0294	CcSEcCtD
Lamivudine—Completed suicide—Varenicline—nicotine dependence	0.0199	0.0284	CcSEcCtD
Lamivudine—NT5C—brain—nicotine dependence	0.0186	0.062	CbGeAlD
Lamivudine—CMPK1—midbrain—nicotine dependence	0.0179	0.0596	CbGeAlD
Lamivudine—PCYT1A—brain—nicotine dependence	0.0174	0.0581	CbGeAlD
Lamivudine—Rhinorrhoea—Varenicline—nicotine dependence	0.0144	0.0206	CcSEcCtD
Lamivudine—Dysphonia—Varenicline—nicotine dependence	0.0142	0.0203	CcSEcCtD
Lamivudine—Acne—Varenicline—nicotine dependence	0.0139	0.0198	CcSEcCtD
Lamivudine—Viral infection—Varenicline—nicotine dependence	0.0129	0.0185	CcSEcCtD
Lamivudine—Musculoskeletal pain—Varenicline—nicotine dependence	0.0118	0.0169	CcSEcCtD
Lamivudine—NME1—brain—nicotine dependence	0.0116	0.0389	CbGeAlD
Lamivudine—Eructation—Varenicline—nicotine dependence	0.0115	0.0164	CcSEcCtD
Lamivudine—CMPK1—brain—nicotine dependence	0.0112	0.0375	CbGeAlD
Lamivudine—Photophobia—Varenicline—nicotine dependence	0.011	0.0157	CcSEcCtD
Lamivudine—NME2—brain—nicotine dependence	0.011	0.0366	CbGeAlD
Lamivudine—Urine output increased—Varenicline—nicotine dependence	0.0106	0.0151	CcSEcCtD
Lamivudine—Mouth ulceration—Varenicline—nicotine dependence	0.0106	0.0151	CcSEcCtD
Lamivudine—Lymphadenopathy—Varenicline—nicotine dependence	0.00994	0.0142	CcSEcCtD
Lamivudine—Sleep disorder—Varenicline—nicotine dependence	0.0098	0.014	CcSEcCtD
Lamivudine—Polyuria—Varenicline—nicotine dependence	0.00966	0.0138	CcSEcCtD
Lamivudine—Deafness—Varenicline—nicotine dependence	0.00948	0.0135	CcSEcCtD
Lamivudine—Injury—Varenicline—nicotine dependence	0.00923	0.0132	CcSEcCtD
Lamivudine—Thirst—Varenicline—nicotine dependence	0.00891	0.0127	CcSEcCtD
Lamivudine—DCK—midbrain—nicotine dependence	0.00889	0.0297	CbGeAlD
Lamivudine—Hypoglycaemia—Varenicline—nicotine dependence	0.00869	0.0124	CcSEcCtD
Lamivudine—Migraine—Varenicline—nicotine dependence	0.00835	0.0119	CcSEcCtD
Lamivudine—Affect lability—Varenicline—nicotine dependence	0.00835	0.0119	CcSEcCtD
Lamivudine—Mood swings—Varenicline—nicotine dependence	0.00804	0.0115	CcSEcCtD
Lamivudine—Liver function test abnormal—Varenicline—nicotine dependence	0.00783	0.0112	CcSEcCtD
Lamivudine—Abdominal pain upper—Varenicline—nicotine dependence	0.00775	0.0111	CcSEcCtD
Lamivudine—Cramp muscle—Varenicline—nicotine dependence	0.00764	0.0109	CcSEcCtD
Lamivudine—Nasopharyngitis—Varenicline—nicotine dependence	0.00759	0.0108	CcSEcCtD
Lamivudine—Abdominal distension—Varenicline—nicotine dependence	0.00738	0.0105	CcSEcCtD
Lamivudine—Dysphagia—Varenicline—nicotine dependence	0.00733	0.0105	CcSEcCtD
Lamivudine—SLC22A6—brain—nicotine dependence	0.00732	0.0244	CbGeAlD
Lamivudine—Bronchitis—Varenicline—nicotine dependence	0.00705	0.0101	CcSEcCtD
Lamivudine—Abdominal discomfort—Varenicline—nicotine dependence	0.00703	0.01	CcSEcCtD
Lamivudine—Pollakiuria—Varenicline—nicotine dependence	0.00677	0.00967	CcSEcCtD
Lamivudine—Hyperglycaemia—Varenicline—nicotine dependence	0.00661	0.00944	CcSEcCtD
Lamivudine—Depression—Varenicline—nicotine dependence	0.00652	0.0093	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00648	0.00925	CcSEcCtD
Lamivudine—Stomatitis—Varenicline—nicotine dependence	0.00637	0.0091	CcSEcCtD
Lamivudine—Hepatobiliary disease—Varenicline—nicotine dependence	0.00618	0.00882	CcSEcCtD
Lamivudine—Epistaxis—Varenicline—nicotine dependence	0.00617	0.0088	CcSEcCtD
Lamivudine—Sinusitis—Varenicline—nicotine dependence	0.00613	0.00875	CcSEcCtD
Lamivudine—Hypoaesthesia—Varenicline—nicotine dependence	0.00584	0.00833	CcSEcCtD
Lamivudine—Connective tissue disorder—Varenicline—nicotine dependence	0.00577	0.00823	CcSEcCtD
Lamivudine—DCK—brain—nicotine dependence	0.00559	0.0187	CbGeAlD
Lamivudine—Erythema multiforme—Varenicline—nicotine dependence	0.00555	0.00792	CcSEcCtD
Lamivudine—ABCC3—brain—nicotine dependence	0.00535	0.0179	CbGeAlD
Lamivudine—Immune system disorder—Varenicline—nicotine dependence	0.0053	0.00757	CcSEcCtD
Lamivudine—Mediastinal disorder—Varenicline—nicotine dependence	0.00529	0.00755	CcSEcCtD
Lamivudine—Chills—Varenicline—nicotine dependence	0.00527	0.00752	CcSEcCtD
Lamivudine—Malnutrition—Varenicline—nicotine dependence	0.00511	0.00729	CcSEcCtD
Lamivudine—Erythema—Varenicline—nicotine dependence	0.00511	0.00729	CcSEcCtD
Lamivudine—Flatulence—Varenicline—nicotine dependence	0.00503	0.00719	CcSEcCtD
Lamivudine—Dysgeusia—Varenicline—nicotine dependence	0.005	0.00714	CcSEcCtD
Lamivudine—ABCG2—midbrain—nicotine dependence	0.00496	0.0166	CbGeAlD
Lamivudine—Back pain—Varenicline—nicotine dependence	0.00494	0.00705	CcSEcCtD
Lamivudine—Muscle spasms—Varenicline—nicotine dependence	0.00491	0.00701	CcSEcCtD
Lamivudine—Tremor—Varenicline—nicotine dependence	0.00479	0.00683	CcSEcCtD
Lamivudine—SLC22A1—brain—nicotine dependence	0.00476	0.0159	CbGeAlD
Lamivudine—Ill-defined disorder—Varenicline—nicotine dependence	0.00474	0.00677	CcSEcCtD
Lamivudine—Anaemia—Varenicline—nicotine dependence	0.00472	0.00674	CcSEcCtD
Lamivudine—Angioedema—Varenicline—nicotine dependence	0.00467	0.00666	CcSEcCtD
Lamivudine—Malaise—Varenicline—nicotine dependence	0.00461	0.00658	CcSEcCtD
Lamivudine—Vertigo—Varenicline—nicotine dependence	0.00459	0.00655	CcSEcCtD
Lamivudine—Syncope—Varenicline—nicotine dependence	0.00458	0.00654	CcSEcCtD
Lamivudine—SLC22A3—brain—nicotine dependence	0.00455	0.0152	CbGeAlD
Lamivudine—Loss of consciousness—Varenicline—nicotine dependence	0.00449	0.00641	CcSEcCtD
Lamivudine—Cough—Varenicline—nicotine dependence	0.00446	0.00636	CcSEcCtD
Lamivudine—Convulsion—Varenicline—nicotine dependence	0.00443	0.00632	CcSEcCtD
Lamivudine—ABCC4—brain—nicotine dependence	0.00441	0.0147	CbGeAlD
Lamivudine—Myalgia—Varenicline—nicotine dependence	0.00435	0.00621	CcSEcCtD
Lamivudine—Chest pain—Varenicline—nicotine dependence	0.00435	0.00621	CcSEcCtD
Lamivudine—Arthralgia—Varenicline—nicotine dependence	0.00435	0.00621	CcSEcCtD
Lamivudine—Anxiety—Varenicline—nicotine dependence	0.00433	0.00619	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00432	0.00617	CcSEcCtD
Lamivudine—Discomfort—Varenicline—nicotine dependence	0.0043	0.00613	CcSEcCtD
Lamivudine—Dry mouth—Varenicline—nicotine dependence	0.00425	0.00607	CcSEcCtD
Lamivudine—Oedema—Varenicline—nicotine dependence	0.00417	0.00595	CcSEcCtD
Lamivudine—Infection—Varenicline—nicotine dependence	0.00414	0.00591	CcSEcCtD
Lamivudine—Shock—Varenicline—nicotine dependence	0.0041	0.00585	CcSEcCtD
Lamivudine—Nervous system disorder—Varenicline—nicotine dependence	0.00409	0.00584	CcSEcCtD
Lamivudine—Thrombocytopenia—Varenicline—nicotine dependence	0.00408	0.00583	CcSEcCtD
Lamivudine—Skin disorder—Varenicline—nicotine dependence	0.00405	0.00578	CcSEcCtD
Lamivudine—Hyperhidrosis—Varenicline—nicotine dependence	0.00403	0.00575	CcSEcCtD
Lamivudine—Anorexia—Varenicline—nicotine dependence	0.00397	0.00567	CcSEcCtD
Lamivudine—Hypotension—Varenicline—nicotine dependence	0.0039	0.00556	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.0038	0.00542	CcSEcCtD
Lamivudine—Insomnia—Varenicline—nicotine dependence	0.00377	0.00538	CcSEcCtD
Lamivudine—ABCC1—brain—nicotine dependence	0.00376	0.0126	CbGeAlD
Lamivudine—Dyspnoea—Varenicline—nicotine dependence	0.00372	0.00531	CcSEcCtD
Lamivudine—Somnolence—Varenicline—nicotine dependence	0.00371	0.00529	CcSEcCtD
Lamivudine—Dyspepsia—Varenicline—nicotine dependence	0.00367	0.00524	CcSEcCtD
Lamivudine—Decreased appetite—Varenicline—nicotine dependence	0.00362	0.00517	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Varenicline—nicotine dependence	0.0036	0.00514	CcSEcCtD
Lamivudine—Fatigue—Varenicline—nicotine dependence	0.00359	0.00513	CcSEcCtD
Lamivudine—Pain—Varenicline—nicotine dependence	0.00357	0.00509	CcSEcCtD
Lamivudine—Constipation—Varenicline—nicotine dependence	0.00357	0.00509	CcSEcCtD
Lamivudine—Feeling abnormal—Varenicline—nicotine dependence	0.00344	0.0049	CcSEcCtD
Lamivudine—Gastrointestinal pain—Varenicline—nicotine dependence	0.00341	0.00487	CcSEcCtD
Lamivudine—Urticaria—Varenicline—nicotine dependence	0.00331	0.00473	CcSEcCtD
Lamivudine—Abdominal pain—Varenicline—nicotine dependence	0.0033	0.0047	CcSEcCtD
Lamivudine—Body temperature increased—Varenicline—nicotine dependence	0.0033	0.0047	CcSEcCtD
Lamivudine—ABCB1—cardiovascular system—nicotine dependence	0.00313	0.0105	CbGeAlD
Lamivudine—ABCG2—brain—nicotine dependence	0.00312	0.0104	CbGeAlD
Lamivudine—Hypersensitivity—Varenicline—nicotine dependence	0.00307	0.00438	CcSEcCtD
Lamivudine—Asthenia—Varenicline—nicotine dependence	0.00299	0.00427	CcSEcCtD
Lamivudine—Pruritus—Varenicline—nicotine dependence	0.00295	0.00421	CcSEcCtD
Lamivudine—Diarrhoea—Varenicline—nicotine dependence	0.00285	0.00407	CcSEcCtD
Lamivudine—Dizziness—Varenicline—nicotine dependence	0.00276	0.00394	CcSEcCtD
Lamivudine—Vomiting—Varenicline—nicotine dependence	0.00265	0.00378	CcSEcCtD
Lamivudine—Rash—Varenicline—nicotine dependence	0.00263	0.00375	CcSEcCtD
Lamivudine—Dermatitis—Varenicline—nicotine dependence	0.00263	0.00375	CcSEcCtD
Lamivudine—Headache—Varenicline—nicotine dependence	0.00261	0.00373	CcSEcCtD
Lamivudine—Nausea—Varenicline—nicotine dependence	0.00248	0.00353	CcSEcCtD
Lamivudine—ABCB1—midbrain—nicotine dependence	0.00245	0.00817	CbGeAlD
Lamivudine—ABCB1—brain—nicotine dependence	0.00154	0.00513	CbGeAlD
